BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23660516)

  • 1. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
    Brault ME; Lauzon C; Autexier C
    Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.
    Zeng XL; Thumati NR; Fleisig HB; Hukezalie KR; Savage SA; Giri N; Alter BP; Wong JM
    Hum Mol Genet; 2012 Feb; 21(4):721-9. PubMed ID: 22058290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.
    MacNeil DE; Lambert-Lanteigne P; Autexier C
    Nucleic Acids Res; 2019 Jun; 47(10):5368-5380. PubMed ID: 30931479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.
    Parry EM; Alder JK; Lee SS; Phillips JA; Loyd JE; Duggal P; Armanios M
    J Med Genet; 2011 May; 48(5):327-33. PubMed ID: 21415081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita: a disorder of defective telomere maintenance?
    Walne AJ; Marrone A; Dokal I
    Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A telomerase component is defective in the human disease dyskeratosis congenita.
    Mitchell JR; Wood E; Collins K
    Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal extension of dyskerin is a dyskeratosis congenita mutational hotspot that modulates interaction with telomerase RNA and subcellular localization.
    Qin J; Garus A; Autexier C
    Hum Mol Genet; 2024 Feb; 33(4):318-332. PubMed ID: 37879098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.
    Cerone MA; Ward RJ; LondoƱo-Vallejo JA; Autexier C
    Cell Cycle; 2005 Apr; 4(4):585-9. PubMed ID: 15753647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.
    Vulliamy T; Beswick R; Kirwan M; Marrone A; Digweed M; Walne A; Dokal I
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8073-8. PubMed ID: 18523010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.
    Machado-Pinilla R; Carrillo J; Manguan-Garcia C; Sastre L; Mentzer A; Gu BW; Mason PJ; Perona R
    Clin Transl Oncol; 2012 Oct; 14(10):755-63. PubMed ID: 22855157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-molecule analysis of the human telomerase RNA.dyskerin interaction and the effect of dyskeratosis congenita mutations.
    Ashbridge B; Orte A; Yeoman JA; Kirwan M; Vulliamy T; Dokal I; Klenerman D; Balasubramanian S
    Biochemistry; 2009 Nov; 48(46):10858-65. PubMed ID: 19835419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells, telomerase and dyskeratosis congenita.
    Mason PJ
    Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyskerin Mutations Present in Dyskeratosis Congenita Patients Increase Oxidative Stress and DNA Damage Signalling in
    Rodriguez-Centeno J; Perona R; Sastre L
    Cells; 2019 Nov; 8(11):. PubMed ID: 31717312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyskeratosis congenita: its link to telomerase and aplastic anaemia.
    Dokal I; Vulliamy T
    Blood Rev; 2003 Dec; 17(4):217-25. PubMed ID: 14556776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.